SMTL ID : 4heu.1 (1 other biounit)

Crystal Structure of PDE10A with a biaryl ether inhibitor ((1-(3-(4-((1H-benzo[d]imidazol-2-yl)amino)phenoxy)pyridin-2-yl)piperidin-4-yl)methanol)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-trimer

Ligands

6 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.78, H.112, D.113, D.223 Ligands: ZN.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.78, A:H.112, A:D.113, A:D.223, H2O.59, H2O.175 ZN.2: 2 residues within 4Å: Chain A: D.113 Ligands: ZN.1 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.113, H2O.52, H2O.53, H2O.55, H2O.56, H2O.175 ZN.10: 5 residues within 4Å: Chain B: H.78, H.112, D.113, D.223 Ligands: ZN.11 6 PLIP interactions: 4 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:H.78, B:H.112, B:D.113, B:D.223, H2O.251, H2O.367 ZN.11: 2 residues within 4Å: Chain B: D.113 Ligands: ZN.10 6 PLIP interactions: 1 interactions with chain B, 5 Ligand-Water interactions Metal complexes: B:D.113, H2O.244, H2O.245, H2O.247, H2O.248, H2O.367 ZN.19: 5 residues within 4Å: Chain C: H.78, H.112, D.113, D.223 Ligands: ZN.20 6 PLIP interactions: 4 interactions with chain C, 2 Ligand-Water interactions Metal complexes: C:H.78, C:H.112, C:D.113, C:D.223, H2O.443, H2O.559 ZN.20: 2 residues within 4Å: Chain C: D.113 Ligands: ZN.19 6 PLIP interactions: 1 interactions with chain C, 5 Ligand-Water interactions Metal complexes: C:D.113, H2O.436, H2O.437, H2O.439, H2O.440, H2O.559

18 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 6 residues within 4Å: Chain A: F.31, E.32, N.33, M.34 Chain C: R.69, R.117 Ligand excluded by PLIP SO4.4: 6 residues within 4Å: Chain A: K.56, L.154, G.156, H.157, N.158, S.161 Ligand excluded by PLIP SO4.5: 8 residues within 4Å: Chain A: V.71, P.72, R.117, G.118, F.119, A.243, E.244, A.247 Ligand excluded by PLIP SO4.6: 4 residues within 4Å: Chain A: L.96, L.205, N.206, R.211 Ligand excluded by PLIP SO4.7: 4 residues within 4Å: Chain A: L.184, M.262, F.278 Ligands: 15J.9 Ligand excluded by PLIP SO4.8: 5 residues within 4Å: Chain A: W.231, P.232, K.235 Chain C: K.253, D.266 Ligand excluded by PLIP SO4.12: 6 residues within 4Å: Chain A: R.69, R.117 Chain B: F.31, E.32, N.33, M.34 Ligand excluded by PLIP SO4.13: 6 residues within 4Å: Chain B: K.56, L.154, G.156, H.157, N.158, S.161 Ligand excluded by PLIP SO4.14: 8 residues within 4Å: Chain B: V.71, P.72, R.117, G.118, F.119, A.243, E.244, A.247 Ligand excluded by PLIP SO4.15: 4 residues within 4Å: Chain B: L.96, L.205, N.206, R.211 Ligand excluded by PLIP SO4.16: 4 residues within 4Å: Chain B: L.184, M.262, F.278 Ligands: 15J.18 Ligand excluded by PLIP SO4.17: 5 residues within 4Å: Chain A: K.253, D.266 Chain B: W.231, P.232, K.235 Ligand excluded by PLIP SO4.21: 6 residues within 4Å: Chain B: R.69, R.117 Chain C: F.31, E.32, N.33, M.34 Ligand excluded by PLIP SO4.22: 6 residues within 4Å: Chain C: K.56, L.154, G.156, H.157, N.158, S.161 Ligand excluded by PLIP SO4.23: 8 residues within 4Å: Chain C: V.71, P.72, R.117, G.118, F.119, A.243, E.244, A.247 Ligand excluded by PLIP SO4.24: 4 residues within 4Å: Chain C: L.96, L.205, N.206, R.211 Ligand excluded by PLIP SO4.25: 4 residues within 4Å: Chain C: L.184, M.262, F.278 Ligands: 15J.27 Ligand excluded by PLIP SO4.26: 5 residues within 4Å: Chain B: K.253, D.266 Chain C: W.231, P.232, K.235 Ligand excluded by PLIP

3 x 15J: (1-{3-[4-(1H-BENZIMIDAZOL-2-YLAMINO)PHENOXY]PYRIDIN-2-YL}PIPERIDIN-4-YL)METHANOL(Non-covalent)

15J.9: 19 residues within 4Å: Chain A: Y.73, L.224, S.226, V.227, T.234, T.237, A.238, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278 Ligands: SO4.7 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.73, A:V.227, A:F.245, A:F.245, A:P.261, A:E.270, A:V.271, A:F.278 Hydrogen bonds: A:T.234 Water bridges: A:G.274 pi-Stacking: A:F.278, A:F.278 15J.18: 19 residues within 4Å: Chain B: Y.73, L.224, S.226, V.227, T.234, T.237, A.238, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278 Ligands: SO4.16 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:Y.73, B:V.227, B:F.245, B:F.245, B:P.261, B:E.270, B:V.271, B:F.278 Hydrogen bonds: B:T.234, B:Y.242 Water bridges: B:G.274 pi-Stacking: B:F.278, B:F.278 15J.27: 19 residues within 4Å: Chain C: Y.73, L.224, S.226, V.227, T.234, T.237, A.238, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278 Ligands: SO4.25 12 PLIP interactions: 12 interactions with chain C Hydrophobic interactions: C:Y.73, C:V.227, C:F.245, C:F.245, C:P.261, C:E.270, C:V.271, C:F.278 Hydrogen bonds: C:T.234 Water bridges: C:G.274 pi-Stacking: C:F.278, C:F.278

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rzasa, R.M. et al., Discovery of selective biaryl ethers as PDE10A inhibitors: Improvement in potency and mitigation of Pgp-mediated efflux. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-12-12

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence